sivelestat has been researched along with Disseminated Intravascular Coagulation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avan, R; Bagheri, M; Habtemariam, S; Khataminia, M; Rezai Ghaleno, H; Sadremomtaz, A; Safdari, M; Saghafi, F; Sahebnasagh, A; Talaei, Z | 1 |
| Fujishima, S; Izumida, H | 1 |
| Aibiki, M; Dote, K; Hamada, H; Higaki, J; Ito, R; Katayama, H; Miyoshi, S; Okura, T | 1 |
| Gando, S; Hayakawa, M; Hoshino, H; Katabami, K; Sawamura, A; Sugano, M; Wada, T | 1 |
| Johno, M; Murakami, K; Nakagaki, T; Okabe, H; Okajima, K; Takatsuki, K; Uchiba, M | 1 |
2 review(s) available for sivelestat and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
Topics: Acute Lung Injury; COVID-19; COVID-19 Drug Treatment; Disseminated Intravascular Coagulation; Glycine; Humans; Proteinase Inhibitory Proteins, Secretory; Respiratory Distress Syndrome; Sulfonamides; Treatment Outcome | 2020 |
[Pharmacological therapies for ARDS].
Topics: Animals; Anticoagulants; Atracurium; Disseminated Intravascular Coagulation; Glycine; Humans; Meta-Analysis as Topic; Methylprednisolone; Neuromuscular Blocking Agents; Protein C; Proteinase Inhibitory Proteins, Secretory; Pulse Therapy, Drug; Randomized Controlled Trials as Topic; Recombinant Proteins; Respiratory Distress Syndrome; Sulfonamides | 2013 |
3 other study(ies) available for sivelestat and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.
Topics: Aged; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Glycine; Humans; Male; Middle Aged; Recombinant Proteins; Respiratory Distress Syndrome; Retrospective Studies; Solubility; Sulfonamides; Thrombomodulin | 2014 |
Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients.
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Glycine; Humans; Male; Middle Aged; Respiratory Distress Syndrome; Retrospective Studies; Sepsis; Serine Proteinase Inhibitors; Sulfonamides; Treatment Outcome | 2010 |
Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Anticoagulants; Antithrombin III; Capillary Permeability; Chemotaxis, Leukocyte; Disseminated Intravascular Coagulation; Endotoxins; Enzyme Activation; Enzyme Inhibitors; Factor Xa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycine; Heparin; Leukocyte Elastase; Leukopenia; Lipopolysaccharides; Lung; Male; Molecular Sequence Data; Pancreatic Elastase; Peroxidase; Protein C; Pulmonary Circulation; Rats; Rats, Wistar; Specific Pathogen-Free Organisms; Sulfonamides; Thrombin; Tumor Necrosis Factor-alpha | 1996 |